BioInnovation Institute Venture House
VC Fund
Copenhagen, Denmark
BioInnovation Institute Venture House is a VC fund in Copenhagen focused on Medical and Health Care. In order to assist the early-stage start-ups that have already benefited from BII, the Venture House program offers an additional financing opportunity in the form of a risk-free convertible loan. The course aims to promote teamwork, scientific advancement, and company acceleration.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries BioInnovation Institute Venture House invests in
Stages BioInnovation Institute Venture House invests in
Countries BioInnovation Institute Venture House invests in
Investment Focus
Industry
- Medical 4 (44%)
- Health Care 3 (33%)
- Biotechnology 3 (33%)
- Therapeutics 2 (22%)
- Medical Device 2 (22%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Visibuilt
|
Visibuilt is to pioneer sustainable road-building solutions by replacing standard asphalt with cutting-edge, environmentally friendly materials. | $1.4M / Convertible Note / Sep 16, 2024 | |
FÆRM
|
FÆRM is a food technology company that uses science to advance traditional cheese production methods, paving the way for the future of nondairy products. They re-design plant-masses to mimic the well-known textures and flavors of cheese in order to create taste experiences unlike anything you've ever had. | $1.4M / Convertible Note / Mar 07, 2024 | |
Droplet IV
|
Droplet IV flushes every IV set at the precise time of medicine termination, ensuring patients receive the best possible treatment. | $1.4M / Convertible Note / Mar 07, 2024 | |
Fuse Vectors
|
Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy. | $1.4M / Convertible Note / Mar 07, 2024 | |
Aiomic
|
Aiomic is a HealthTech company developing AI-enhanced reporting and prediction tools to combat postoperative complications. It offers automated tracking and real-time risk assessment using the company's Surgical Advanced Warning (SAW) system that functions as a business intelligence tool for hospitals, a decision support tool for healthcarepractitioners, and an individualized patient empowerment tool by allowing patients to gain insight into their risk profiles. | Convertible Note / Mar 16, 2023 | |
Ousia Pharma
|
Ousia Pharma is a biotech startup that focuses on the design and development of pharmacotherapies to improve the health and lives of people living with obesity and metabolic diseases. The company uses a targeting approach in which peptides are used to deliver modulators of synaptic plasticity to the brain to drive potent and sustained weight losswithout compromising safety.It was founded in 2022 and is headquartered in Copenhagen, Denmark. | Convertible Note / Mar 16, 2023 | |
Nordic Virtual Pastures
|
NVP aims to accelerate the cultured meat revolution by introducing our ground-breaking ‘Virtual Media’ for the propagation of meat cells. The sustainability of our product and low cost will further optimize the production and therefore allow the world to continue eating meat without the ethical and environmental issues that today surround theconventional meat industry.The company was founded in 2021 and is headquartered in Copenhagen, Denmark. | $1.4M / Convertible Note / Mar 16, 2023 | |
TetraKit Technologies
|
TetraKit Technologies is a click chemistry-based radiochemical platform developing therapeutics for metastatic cancer. The company offers targeted radionuclide therapy and nuclear imaging platform for the diagnosis of cancer and provides offers radiopharmaceuticals fluorine-18 and astatine-211 as radionuclide pairs for PET imaging and targetedalpha-radionuclide therapy.It was founded in 2021 and is headquartered in Copenhagen, Denmark. | Convertible Note / Mar 16, 2023 | |
MELLO
|
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics. The company aims to overcome a number of industry-wide challenges which currently prevent optimizing probiotic benefits. | Convertible Note / Mar 16, 2023 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does BioInnovation Institute Venture House invest in?
BioInnovation Institute Venture House invests primarily in Medical, Health Care and Biotechnology startups, most often at Convertible Note stage. Most of the 9 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did BioInnovation Institute Venture House last invest?
The most recent investment recorded for BioInnovation Institute Venture House closed in Sep 2024. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
